A startup using regenerative medicine technologies to produce and supply homogeneous, high-precision blood cells at scale. It streamlines infectious disease research and the evaluation of pharmaceuticals and functional materials for efficacy and safety, while also providing research cells, testing cells, and diagnostic kits.
[画像: https://prtimes.jp/i/55964/3/resize/d55964-3-0c0cf85cdee7484e8db4-0.jpg ] ■受賞概要 当社は、再生医療技術を用いてヒトiPS細胞などから誘導した不死化ミエロイド系細胞（Mylc細胞：免疫細胞の一...
[画像: https://prtimes.jp/i/55964/2/resize/d55964-2-ff514c86260ac62f672a-0.jpg ] マイキャン・テクノロジーズ株式会社 (本社：京都府京都市、代表取締役：宮崎 和雄) は、国立研究開発法人 新エネルギー・...
[画像: https://prtimes.jp/i/55964/1/resize/d55964-1-65f8b292b1973b3cf657-0.png ] マイキャン・テクノロジーズ株式会社 (本社：京都府京都市、代表取締役：宮崎 和雄) は、リアルテックファンド3号投資事...
A startup providing the “mui Smart Living” platform for smart homes. It supports corporate digital transformation with user-friendly UI/UX and compliance with standard specifications, contributing to enhanced customer experiences in the energy and housing sectors.
We sell ceramic filter columns for the purification and high-purity refinement of fine chemicals, including pharmaceuticals. Our columns are used from chemical and pharmaceutical research through to manufacturing, delivering approximately five times the separation performance of conventional products to improve target-compound purity. They are reusable, enabling significant cost reduction, and can be deployed immediately by simply replacing existing disposable cartridges on current equipment. From Kyoto, we provide high-performance, environmentally responsible, and cost-effective purification technology to customers worldwide.
Using catalysts, this startup decomposes mixed, multilayer, and contaminated waste plastics and organic waste at 200–300°C, converting them into monomers, hydrogen, alcohols, and other substances. It achieves resource circulation and waste reduction.
A deep tech startup developing a personalized shoe manufacturing platform that integrates 3D scanning, automated design algorithms, and 3D printing. DIFF.3D—which automatically designs optimal footwear from 3D foot scan data and delivers shoes on demand—is set to launch in June 2026. The platform addresses Japan's approximately 25 million "shoe refugees" who struggle to find well-fitting off-the-shelf footwear, while also pursuing a B2B model as an industry infrastructure for other shoe brands.
